All posts
-
Viking Therapeutics’ weight-loss pill disappoints in phase 2
Eli Lilli and Novo Nordisk have actually formerly offered arise from stage 3 research studies with their tablet variations.
-
Investment economist disappointed in Zealand Pharma financial results
A share buyback could confirm investors’ belief in the significant unfulfilled price potential, according to Nordnet investment economist.
-
Gold, gangs and the rise of narco-miners
Historical rate rally entices offenders and paramilitaries right into illegal mining from the Amazon to Sudan
-
Tariffs Set to Turn Holiday Shopping Season into High-Stakes Gamble
What was once the season of abundance may instead feel like one of triage, where both retailers and consumers make hard choices about what can be afforded.
-
CORL Technologies and RiskRecon by Mastercard Partner to Deliver Continuous, Actionable Third-Party Risk Intelligence for Healthcare
ATLANTA–( SERVICE CABLE)– Medical care continues to be one of the most targeted market for cyberattacks, with third-party vendors linked most of significant violations.…
-
Energy Vault et le turc Astor Enerji lancent un partenariat stratégique mondial avec des déploiements BESS pour un total de 2 GWh et 1 GW d’achat de transformateurs à Astor Enerji
WESTLAKE TOWN, Californie et ISTANBUL–( ORGANIZATION CORD)– Power Safe Holdings, Inc. (NYSE: NRGV), leader mondial des options de stockage d’énergie à l’éch…
